Investigation of the effects of Hedyotis diffusa Willd. on metabolic dysfunction-associated steatotic liver disease (MASLD) in HFD-induced mice by Bong Kyu Park Doctor of Philosophy in Science Graduate School of Kyung Hee University Advised by Prof. B...
Investigation of the effects of Hedyotis diffusa Willd. on metabolic dysfunction-associated steatotic liver disease (MASLD) in HFD-induced mice by Bong Kyu Park Doctor of Philosophy in Science Graduate School of Kyung Hee University Advised by Prof. Bo Hyoung Jang Obesity is a global health concern closely associated with metabolic disorders such as insulin resistance, metabolic dysfunction-associated steatotic liver disease (MASLD), and cardiovascular complications. This study aimed to evaluate the anti-obesity effects of Hedyotis diffusa Willd. extract (HDE) in a high-fat diet (HFD)-induced obese mouse model. HDE administration significantly reduced body weight gain without altering food intake, suggesting its ability to regulate energy metabolism. Moreover, HDE improved glucose tolerance and insulin sensitivity, as evidenced by lower fasting glucose levels and enhanced peripheral glucose uptake. The treatment also inhibited adipocyte hypertrophy in white adipose tissue (WAT) and activated brown adipose tissue (BAT), promoting energy expenditure. HDE further demonstrated protective effects on liver health by reducing lipid accumulation and preventing the progression of MASLD. Additionally, serum lipid profiles were normalized, with HDE reducing triglycerides and LDL cholesterol while increasing HDL cholesterol levels, thereby mitigating the risk of cardiovascular diseases. These findings indicate that HDE exerts multi-faceted effects in controlling obesity and its related metabolic disorders through various pathways. However, further research is necessary to understand the precise molecular mechanisms involved and to validate these effects in human clinical trials, establishing HDE as a potential therapeutic option for obesity and MASLD management. Key words Hedyotis diffusa Willd., obesity, insulin resistance, brown adipose tissue, metabolic dysfunction-associated steatotic liver disease(MASLD).